Neuropeptidomics demonstrated distinct profilesof neuropeptides in AD compared to controls consisting of neuropeptidesderived from chromogranin A (CHGA) and granins, VGF (nerve growthfactor inducible), cholecystokinin, and others. Here, CHGA is linked to Alzheimer disease.